Takeover Panel raps BET
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The Takeover Panel yesterday publicly rapped BET for misleading investors in a statement rejecting the higher bid for the group announced by Rentokil on Thursday. Indicating the seriousness with which it viewed the matter, the City watchdog issued a rare public reprimand criticising BET for not making a valid comparison between its share price and the value of the new offer.
The announcement from BET on Thursday valued Rentokil's revised offer at 209.8p a share, excluding a promised dividend of 4p, and claimed that it represented an increase of just 1.1 percent over the previous night's closing price. The Panel executive said it was "not satisfied that this was a valid comparison to have made because an offer value ex the BET dividend was compared with a BET share price which was cum all future dividends." BET has already forecast a final dividend of 3.7p for last year, which is deemed to be included in its share price.
Had the comparison been made between Rentokil's increased offer and BET's share price prior to the the announcement of the new offer the increase would have been 3.01 per cent, the Panel said. It called on BET not to make further comparisons based on the value of Rentokil's increased offer excluding the BET dividend.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments